Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053).
D000293:Adolescent; D000328:Adult; D002648:Child; D002699:Chlorambucil / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008727:Methotrexate / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging / Q000188:drug therapy; D009365:Neoplasm Regression, Spontaneous / Q000139:chemically induced; D011859:Radiography; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D013280:Stomatitis / Q000139:chemically induced; D013492:Suppuration / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D002699:Chlorambucil; D003609:Dactinomycin; D003520:Cyclophosphamide; D008727:Methotrexate